Cite

HARVARD Citation

    Wu, K. et al. (n.d.). Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Lung cancer. 88 (2), pp. 187-194. [Online]. 
  
Back to record